FDA advisory panel rejects widespread Pfizer booster shots
- Country:
- United States
An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.
The vote Friday, 16-3, was a blow to the Biden administration's effort to shore up people's protection against the virus amid the highly contagious delta variant.
Over several hours of discussion, members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses.
And they complained that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the US experience.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Americans
- Food and Drug Administration
- Pfizer
- Biden
- Israeli
ALSO READ
Indian-Americans Bhatia, Theegala ensure weekend action, Woods sets cuts record at Augusta
Palestinian Americans fundraise for Gaza, as aid groups receive record donations
Asian Americans and Pacific Islanders in the US show higher levels of belief in climate change: AP-NORC poll
Asian Americans and Pacific Islanders in US more likely to believe in climate change: AP-NORC poll
UnitedHealth says hackers possibly stole large number of Americans' data